Condition
Chronic Ulcer of Lower Extremity
Total Trials
5
Recruiting
1
Active
3
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (2)
P 4 (1)
Trial Status
Active Not Recruiting2
Completed1
Recruiting1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05855499Not ApplicableActive Not RecruitingPrimary
Plasma On Chronic Wounds for Epidermal Regeneration
NCT06878482Phase 4RecruitingPrimary
Effect of Blood Flow by Botulinum Toxin Injection for Severe Peripheral Artery Occlusive Disease
NCT04667416Phase 2Active Not RecruitingPrimary
Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities
NCT02045303Not ApplicableCompletedPrimary
Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol
NCT00823095Phase 2TerminatedPrimary
Topical Nitric Oxide Trial in Chronic Non-Healing Wounds
Showing all 5 trials